oncology live logo

Vol. 23/No. 10 | OncologyLive

Combinations Gain Momentum as First-Line Treatments for Unresectable Hepatocellular Carcinoma

May 25, 2022

A panel of hepatobiliary tumor experts discuss several pivotal phase 3 clinical trials examining combination approaches that have expanded or are anticipated to expand the treatment armamentarium for treatment-naïve patients with unresectable hepatocellular carcinoma.

New Programs Unlock Patient Access to Oncology Care

May 19, 2022

Developing a system with a patient-centric focus, investigators at Yale Cancer Center and Moffitt Cancer Center initiated pilot programs to offer patients better access to care following a diagnosis of cancer.

The Saga of Regional Therapy in the Treatment of Ovarian Cancer

May 17, 2022

Despite numerous well-designed and conducted randomized trials, a definitive answer to the role of specific disease management remains unclear, particularly in the discussions of the optimal role for the regional delivery of cytotoxic chemotherapy in the treatment of patients with ovarian cancer.